NCT05448339已完成不适用
The Value of Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 个研究点 分布在 1 个国家目标入组 197 人开始时间: 2013年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 197
- 试验地点
- 1
- 主要终点
- Underwent LT
研究概览
简要总结
To investigate the value of tumor feeding vessels deprivation combined with tyrosine kinase inhibitor in liver transplantation. Patients are enrolled into two groups according to the downstaging therapy they undergo before transplantion.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Underwent LT
时间窗: January 2013 and December 2020
Underwent LT
Successful downstaging
时间窗: January 2013 and December 2020
Successful downstaging
次要结局
- Survival time of patients(January 2013 and December 2020)
- AFP reduction of patients(January 2013 and December 2020)
- Recurrence of patients(January 2013 and December 2020)
研究者
Lin Zhong
director
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
2 期
Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic SyndromeEosinophilic Myeloid NeoplasmHypereosinophilic SyndromeNCT00044304National Institute of Allergy and Infectious Diseases (NIAID)70
招募中
不适用
Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid LeukemiaChronic Myeloid LeukemiaNCT05130138Centre Hospitalier Universitaire de Saint Etienne100
Unknown
2 期
TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive Acute Lymphocytic LeukemiaStem Cell TransplantationMinimal Residual DiseaseNCT01883219Nanfang Hospital, Southern Medical University80
Unknown
3 期
Evaluation of TK3 in Improving Quality of Life in Patients With Malignancy Under ChemotherapyCancerNCT01168206Lavilabor Natural Products Ltd80
招募中
4 期
Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO): a prospective, multicentre, single-arm studychronic leukemiachronic myeloid leukemiaCML10018849NL-OMON52067Radboud Universitair Medisch Centrum140